Otto Bock HealthCare GmbH, commonly known as Otto Bock, is a leading global provider of innovative medical technology, headquartered in Duderstadt, Germany. Founded in 1919, the company has established itself as a pioneer in the fields of prosthetics, orthotics, and rehabilitation solutions, serving patients across Europe, North America, and Asia. With a commitment to enhancing mobility and quality of life, Otto Bock offers a diverse range of products, including advanced prosthetic limbs and custom orthotic devices. Their unique approach combines cutting-edge technology with patient-centric design, ensuring optimal functionality and comfort. Recognised for its excellence, Otto Bock has received numerous awards and maintains a strong market position, continually setting benchmarks in the healthcare industry.
How does Otto Bock's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Otto Bock's score of 53 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Otto Bock reported total carbon emissions of approximately 89,153,340 kg CO2e across all scopes. This includes 8,915,340 kg CO2e from Scope 1, 12,749,860 kg CO2e from Scope 2 (market-based), and a significant 65,488,140 kg CO2e from Scope 3 emissions. The Scope 3 emissions are further broken down into categories such as purchased goods and services (186,780,370 kg CO2e) and employee commute (6,794,900 kg CO2e). In 2023, the company’s emissions were slightly lower, with total emissions of about 85,239,000 kg CO2e, comprising 8,523,900 kg CO2e from Scope 1, 12,511,480 kg CO2e from Scope 2 (market-based), and 64,203,620 kg CO2e from Scope 3. The trend shows a gradual increase in emissions over the years, with 2022 emissions at approximately 85,000,000 kg CO2e and 2021 at about 83,000,000 kg CO2e. Otto Bock has not set specific reduction targets through the Science Based Targets initiative (SBTi) and has had commitments that have since expired. The company is currently not committed to net-zero emissions. Their emissions data is cascaded from their parent company, Ottobock SE & Co. KGaA, reflecting their corporate family relationship. Overall, while Otto Bock has made strides in reporting emissions, their lack of active reduction targets and commitments raises questions about their long-term climate strategy in the healthcare technology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 9,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 87,086,632 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Otto Bock's Scope 3 emissions, which decreased by 3% last year and increased by approximately 173% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Otto Bock has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Common questions about Otto Bock's sustainability data and climate commitments